Skip to main content

Verified by Psychology Today

Ketamine

Elon Musk and Ketamine: A Dose of Science

An examination of ketamine’s benefits and side effects.

In recent years, discussions regarding celebrity lifestyles have increasingly included claims about drug use and unconventional health practices. Among the most scrutinized is Elon Musk. Recent reports—including a CNN interview with Don Lemon and an analysis by The Wall Street Journal—have spotlighted Musk’s self-reported use of ketamine and other substances.

Here, I examine ketamine’s pharmacological profile, documented benefits, and potential side effects. I aim to provide a balanced and evidence-based analysis, noting that while the medical literature on ketamine is extensive and robust, the specific claims regarding Musk’s habits, though reported by him directly, require more specifics regarding how they affect his mental state.

Ketamine: Medical Applications

Ketamine was originally developed in the 1960s as a dissociative anesthetic. Over the past two decades, ketamine has emerged as a groundbreaking treatment for refractory depression and suicidal ideation, particularly in patients who do not respond to conventional antidepressants.

The rapid antidepressant effects of ketamine have been documented in several clinical studies. For example, research by Zarate and colleagues (2006) demonstrated significant improvements in mood within hours of administration in patients with treatment-resistant depression. Subsequent studies and systematic reviews have reinforced these findings, suggesting that ketamine’s effects—though often transient—may offer a crucial therapeutic window for intervention in severe depressive episodes.

Beyond depression, ketamine is also used for pain management and as an adjunct in anesthesia. Its dissociative properties have made it particularly valuable in emergency settings, where rapid sedation and analgesia can be life-saving. However, these benefits are not without risk. The potential side effects of ketamine include dissociative experiences that may lead to confusion or impaired motor coordination, cognitive disturbances, and, with repeated misuse, the risk of developing a substance use disorder. These risks underscore the importance of administering ketamine in a controlled, clinical setting.

Alleged Drug Use in High-Profile Figures: The Case of Elon Musk

Elon Musk
Elon Musk
Source: Lexica AI

Recent media reports have sparked debates about whether Musks's personal habits, including the use of ketamine and other drugs, might play a role in his creative or stress-management routines. This, in turn, could affect his functioning as a CEO and a political strongman.

In addition to ketamine, other reports—such as those published by Nationalworld and The Wall Street Journal—have hinted at Musk’s engagement with substances that are classified as illegal or that fall outside typical medical use. Such allegations have profound implications for his personal life and public perceptions of his leadership.

Here, I approach these claims with some caution. Media reports on celebrity behavior can be sensationalized. While the discussion of ketamine in the context of Musk’s lifestyle has gained traction in popular media, it should not be taken as definitive proof of routine or problematic substance use, though he does say he indulges in low-dose ketamine every week.

Potential Benefits and Side Effects of Ketamine

Ketamine’s profile as a rapid-acting antidepressant has revolutionized approaches to treatment-resistant depression. Its benefits include:

  • Rapid Onset of Action: Unlike traditional antidepressants that may take weeks to achieve full effect, ketamine can alleviate depressive symptoms within hours.
  • Reduction in Suicidal Ideation: The swift alleviation of severe depressive symptoms can be life-saving in individuals with acute suicidal tendencies.
  • Versatility in Medical Settings: Its use in anesthesia and pain management underscores ketamine’s versatility in clinical practice.

Despite these benefits, ketamine is not without side effects. Reported adverse reactions include:

  • Dissociative and Psychotomimetic Effects: At higher doses or with improper use, ketamine can induce hallucinations and a sense of detachment from reality.
  • Cognitive Impairment: Chronic use has been associated with impairments in memory and executive function.
  • Potential for Abuse: There is a documented risk of psychological dependence, particularly when ketamine is used outside a controlled medical environment.

Other Substances and Their Implications

The other drugs alleged in various media reports about Elon Musk are less clearly defined, but they reportedly include substances that fall under the category of “illegal drugs.” Although details remain speculative, it is helpful to consider the broader spectrum of substances that are sometimes discussed in the context of high-profile figures:

  • Psychedelics (e.g., LSD, psilocybin): These drugs have been researched for their potential to treat depression, anxiety, and post-traumatic stress disorder (PTSD). Studies indicate that when administered in controlled, therapeutic environments, psychedelics can promote profound shifts in perception and emotional processing. However, unsupervised use can lead to unpredictable psychological effects and may exacerbate underlying mental health conditions.
  • Stimulants and Other Mood-Altering Substances: Stimulants increase alertness and concentration. Mood-Altering Substances do just that; they alter mood. While these drugs can enhance performance and a euphoric mood in the short term, they also carry risks such as increased heart rate, potential for addiction, and long-term cardiovascular damage.

The potential benefits of these substances, particularly in clinical trials, are being actively explored. For instance, recent research on psychedelics has shown promising results in alleviating symptoms of mental illness, much like ketamine. Yet, without the oversight of clinical protocols, their recreational use remains fraught with legal, physiological, and psychological dangers.

Broader Implications and Public Perception

The intersection of celebrity culture and drug use often amplifies the public discourse surrounding these substances. High-profile figures like Elon Musk are frequently held up as examples—both positive and negative—of the potential benefits and perils of drug use. On one hand, the therapeutic potential of ketamine and even certain psychedelics is supported by rigorous scientific research, suggesting that under proper medical supervision, these substances can provide significant relief for individuals suffering from mental health conditions. On the other hand, unsupervised or recreational use carries substantial risks, including legal ramifications, cognitive impairments, and the potential for addiction.

Conclusion

Ketamine stands as a unique example of a substance with both remarkable therapeutic potential and significant risks. Its rapid antidepressant effects have opened new avenues for treating severe mental health conditions, yet its capacity to induce dissociative states and cognitive disturbances calls for cautious, supervised use. The media reports linking Elon Musk to ketamine—and other drug use—illustrate the challenges of separating verified scientific fact from speculative commentary. While the benefits of ketamine in clinical settings are well-documented, the broader narrative of celebrity drug use remains mired in uncertainty and sensationalism.

In summary, the current literature supports the use of ketamine in carefully controlled medical environments, where its benefits can be maximized and its risks mitigated. In contrast, the allegations concerning Elon Musk’s personal use of ketamine and other substances should be viewed with caution and concern. He says ketamine benefits him. We can only hope that is the case.

References

Don Lemon Interview March 18, 2024

Wall Street Journal January 6, 2024

Zarate, C.A., et al. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry. Aug;63(8):856-64

Aan Het Rot, M., et al. (2012). Ketamine for depression: Where do we go from here? Biological Psychiatry. Oct 1;72(7):537-47

Domino, E.F. (2010). Taming the Ketamine Tiger. Anesthesiology. Sep;113(3):678-84

Le Daré B, Pelletier R, Morel I, Gicquel T. (2022) Histoire de la kétamine : une molécule ancienne qui a toujours la cote [History of Ketamine: An ancient molecule that is still popular today]. Ann Pharm Fr. 2022 Jan;80(1):1-8

Nationalworld, January 21, 2025

advertisement
More from Shirley M. Mueller M.D.
More from Psychology Today